Molecular targets for flavivirus drug discovery.
Flaviviruses are a major cause of infectious disease in humans. Dengue virus causes an estimated 50 million cases of febrile illness each year, including an increasing number of cases of hemorrhagic fever. West Nile virus, which recently spread from the Mediterranean basin to the Western Hemisphere, now causes thousands of sporadic cases of encephalitis annually. Despite the existence of licensed vaccines, yellow fever, Japanese encephalitis and tick-borne encephalitis also claim many thousands of victims each year across their vast endemic areas. Antiviral therapy could potentially reduce morbidity and mortality from flavivirus infections, but no effective drugs are currently available. This article introduces a collection of papers in Antiviral Research on molecular targets for flavivirus antiviral drug design and murine models of dengue virus disease that aims to encourage drug development efforts. After reviewing the flavivirus replication cycle, we discuss the envelope glycoprotein, NS3 protease, NS3 helicase, NS5 methyltransferase and NS5 RNA-dependent RNA polymerase as potential drug targets, with special attention being given to the viral protease. The other viral proteins are the subject of individual articles in the journal. Together, these papers highlight current status of drug discovery efforts for flavivirus diseases and suggest promising areas for further research.
Sampath
Aruna
A
National Center for Natural Product Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA.
Padmanabhan
R
R
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D055808:Drug Discovery; D005416:Flavivirus / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D018177:Flavivirus Infections / Q000188:drug therapy / Q000378:metabolism / Q000821:virology*; D016679:Genome, Viral; D006801:Humans; D014764:Viral Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism
D000998:Antiviral Agents; D014764:Viral Proteins
Traffic. 2005 Nov;6(11):967-77
16190978
J Virol. 1993 Nov;67(11):6797-807
8411382
Int J Biochem Cell Biol. 2007;39(3):606-14
17188926
J Biol Chem. 2007 Mar 23;282(12):8873-82
17276984
J Gen Virol. 2007 Aug;88(Pt 8):2223-2227
17622626
J Virol. 2005 Oct;79(20):13105-15
16189012
J Virol. 1991 Nov;65(11):6042-50
1833562
Science. 2008 Mar 28;319(5871):1834-7
18369148
J Biol Chem. 2004 Nov 19;279(47):48535-42
15322074
Science. 2008 Mar 28;319(5871):1830-4
18369147
Curr Opin Infect Dis. 2001 Feb;14(1):13-6
11979109
J Virol Methods. 2001 Mar;92(1):37-44
11164916
Virology. 2006 Mar 1;346(1):53-65
16325883
J Biol Chem. 2004 Mar 26;279(13):12141-51
14699096
Antiviral Res. 2007 Dec;76(3):222-31
17662475
Antivir Ther. 2008;13 Suppl 1:31-6
18432161
Antiviral Res. 2008 Oct;80(1):1-10
18571739
Chem Biol Drug Des. 2006 Jan;67(1):13-26
16492145
J Biol Chem. 2005 Jun 24;280(25):23698-708
15855154
Biochem Biophys Res Commun. 2005 May 20;330(4):1237-46
15823576
Science. 1985 Aug 23;229(4715):726-33
4023707
J Biol Chem. 2001 Dec 7;276(49):45762-71
11581268
Curr Issues Mol Biol. 2007 Jan;9(1):1-20
17263143
Virology. 1989 Aug;171(2):637-9
2548336
AIDS Patient Care STDS. 2008 Jun;22(6):449-57
18479202
Expert Opin Investig Drugs. 2007 Jan;16(1):11-23
17155850
J Virol. 1997 Dec;71(12):9608-17
9371625
Arch Virol. 1993;128(1-2):111-21
8418788
Protein Pept Lett. 2003 Feb;10(1):19-26
12625822
J Virol. 2005 Aug;79(16):10268-77
16051820
J Antimicrob Chemother. 2007 Nov;60(5):981-6
17872917
J Virol. 2007 Oct;81(20):11256-66
17686844
J Virol. 2006 Sep;80(17):8362-70
16912287
Antiviral Res. 2008 Apr;78(1):9-25
18313769
Virology. 1987 Apr;157(2):330-7
3029975
Virology. 1993 Apr;193(2):888-99
8460492
J Virol. 2005 Aug;79(16):10278-88
16051821
J Virol. 2006 Jul;80(13):6686-90
16775356
Biochem J. 2006 Jan 15;393(Pt 2):503-11
16229682
Protein Expr Purif. 2007 May;53(1):87-96
17174105
Antimicrob Agents Chemother. 2008 Sep;52(9):3385-93
18606844
Curr Opin Infect Dis. 2001 Dec;14(6):757-64
11964896
Arch Biochem Biophys. 2007 Jan 15;457(2):187-96
17184724
Arch Virol. 1992;125(1-4):177-91
1322651
J Biol Chem. 2001 May 11;276(19):15581-91
11278787
Bioorg Med Chem. 2007 Dec 15;15(24):7795-802
17888664
J Virol. 1999 Apr;73(4):3108-16
10074162
Virology. 2008 Apr 10;373(2):426-36
18201743
Biochemistry. 2005 Jul 19;44(28):9637-44
16008349
J Virol. 2004 Aug;78(15):8078-84
15254179
J Med Chem. 2006 Nov 2;49(22):6585-90
17064076
Arch Virol. 1996;141(3-4):685-99
8645104
Virology. 1999 May 25;258(1):108-17
10329573
J Virol. 2008 Jan;82(1):173-83
17942558
J Virol. 2001 Nov;75(22):10787-99
11602720
Antimicrob Agents Chemother. 2007 Mar;51(3):845-51
17194832
J Biol Chem. 1999 Nov 19;274(47):33714-22
10559263
J Biol Chem. 2007 Apr 6;282(14):10678-89
17287213
Virology. 2006 Jul 20;351(1):145-58
16631221
J Virol. 2007 May;81(9):4881-5
17301152
J Virol. 1993 Oct;67(10):6152-8
8396675
Nat Med. 2004 Dec;10(12 Suppl):S98-109
15577938
J Virol. 2007 Apr;81(8):4381-5
17287285
J Virol. 2008 May;82(10):4731-41
18337583
J Biol Chem. 2001 Oct 26;276(43):39926-37
11546770
Eur J Biochem. 2003 Apr;270(8):1645-53
12694177
J Biol Chem. 2007 Apr 27;282(17):12883-92
17337448
Proc Natl Acad Sci U S A. 1990 Nov;87(22):8898-902
2147282
J Biochem Mol Biol. 2002 Mar 31;35(2):206-12
12297031
Nat Struct Mol Biol. 2006 Apr;13(4):372-3
16532006
J Gen Virol. 2001 Apr;82(Pt 4):735-745
11257177
J Virol. 2007 May;81(9):4753-65
17301146
J Virol. 1997 Jan;71(1):291-8
8985349
Antivir Chem Chemother. 2007;18(2):103-9
17542155
J Virol. 1990 Sep;64(9):4364-74
2143543
Antiviral Res. 2008 Apr;78(1):1-8
18243346
Bioorg Med Chem Lett. 2006 Jan 1;16(1):40-3
16246563
J Virol. 2006 May;80(9):4623-32
16611922
Virology. 1998 Jun 5;245(2):203-15
9636360
J Virol. 2007 Jun;81(12):6471-81
17526891
Protein Sci. 2007 May;16(5):795-806
17400917
J Biol Chem. 2006 Feb 24;281(8):4624-37
16371364
J Exp Med. 2005 Nov 7;202(9):1179-84
16260489
J Virol. 2005 Jul;79(13):8004-13
15956546
J Med Chem. 2003 Sep 11;46(19):4149-64
12954067
J Virol. 2007 May;81(9):4501-9
17301157
Nat Rev Microbiol. 2005 Jan;3(1):13-22
15608696
J Virol. 2003 Jun;77(12):7131-8
12768034
Curr Med Chem. 2006;13(17):2003-20
16842194
Bioorg Med Chem. 2006 Dec 15;14(24):8396-404
17010618
Mol Pharmacol. 2006 Apr;69(4):1461-7
16421290
Biochem J. 2007 Feb 1;401(3):743-52
17067286
J Biol Chem. 2005 Aug 5;280(31):28766-74
15932883
Virology. 1993 Mar;193(1):1-10
8382392
J Virol. 1991 May;65(5):2467-75
2016768
J Mol Biol. 2007 Sep 21;372(3):723-36
17686489
J Biol Chem. 2003 Jul 4;278(27):24388-98
12700232
Microbes Infect. 2002 Nov;4(13):1301-7
12443894
J Gen Virol. 2006 Oct;87(Pt 10):2755-2766
16963734
Protein Expr Purif. 2007 Apr;52(2):334-9
17189703
J Virol. 2008 Jul;82(14):7047-58
18448528
J Virol. 1993 Feb;67(2):989-96
8380474
Recent Pat Antiinfect Drug Discov. 2006 Jan;1(1):45-55
18221133
J Gen Virol. 2002 Dec;83(Pt 12):3093-3102
12466486
J Mol Med (Berl). 2002 Feb;80(2):86-95
11907645
Assay Drug Dev Technol. 2007 Dec;5(6):737-50
18181690
Antiviral Res. 2008 Oct;80(1):23-35
18611413
J Virol. 2003 Aug;77(16):8831-42
12885902
Antimicrob Agents Chemother. 2007 Jul;51(7):2642-5
17452483
EMBO J. 2002 Jun 3;21(11):2757-68
12032088
J Biol Chem. 2005 Jan 28;280(4):2896-903
15494419
J Virol. 2007 May;81(9):4412-21
17301144
J Gen Virol. 2008 Mar;89(Pt 3):636-641
18272753
Curr Top Med Chem. 2007;7(13):1273-89
17627557
J Exp Med. 2003 Apr 7;197(7):823-9
12682107
J Biol Chem. 2005 Jul 22;280(29):27412-9
15917225
Virology. 1996 Feb 15;216(2):317-25
8607261
J Biol Chem. 2003 Dec 5;278(49):49164-70
12966103
Antiviral Res. 2008 Apr;78(1):69-78
18031836
Antiviral Res. 2000 Feb;45(2):135-47
10809022
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3414-9
14993605
J Mol Biol. 2007 Sep 14;372(2):444-55
17658551
Virology. 2004 Oct 25;328(2):208-18
15464841
Antiviral Res. 2004 Aug;63(2):67-77
15321702
J Biol Chem. 1997 Dec 5;272(49):30715-23
9388208
Bioorg Med Chem. 2003 Jun 12;11(12):2551-68
12757723
J Gen Virol. 2006 Sep;87(Pt 9):2605-2614
16894199
Antiviral Res. 2008 Oct;80(1):11-22
18585795
Cell. 2007 Apr 20;129(2):263-75
17448989
J Biol Chem. 2000 Apr 7;275(14):9963-9
10744671
Nucleic Acids Res. 1989 May 25;17(10):3889-97
2543956
J Virol. 2001 Oct;75(20):9633-43
11559795
Antiviral Res. 2008 Nov;80(2):87-93
18619493
Virology. 2008 Apr 25;374(1):170-85
18234265
J Virol. 1993 Apr;67(4):2034-42
8383225
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6895-900
11371613
J Virol. 2004 Mar;78(6):3178-83
14990739
J Virol. 1992 Dec;66(12):7549-54
1433530
J Virol. 2006 Jan;80(1):149-60
16352539
J Virol. 2003 Jun;77(12):7143-9
12768036
Antimicrob Agents Chemother. 2002 May;46(5):1231-9
11959550
J Virol. 1997 Sep;71(9):6650-61
9261387
Med Chem. 2006 Nov;2(6):577-89
17105439
J Virol. 1995 Feb;69(2):695-700
7529335
J Gen Virol. 2006 Jul;87(Pt 7):1947-1952
16760396
Curr Med Chem. 2007;14(8):883-915
17430143
Res Initiat Treat Action. 2003 Spring;8(2):25-7
12845775
Drug News Perspect. 2003 Jul-Aug;16(6):355-62
12973446
J Biol Chem. 2006 Dec 15;281(50):38448-58
17052977
J Gen Virol. 2001 Jul;82(Pt 7):1647-1656
11413376
J Virol. 1999 Jun;73(6):5201-6
10233989
Antiviral Res. 2008 Nov;80(2):94-101
18674567
J Gen Virol. 1991 Apr;72 ( Pt 4):851-8
1826736
Bioorg Med Chem Lett. 2006 Jan 1;16(1):36-9
16246553
J Med Chem. 2003 Oct 23;46(22):4776-89
14561097
J Virol. 2007 Apr;81(8):3891-903
17267492
J Virol. 1986 Dec;60(3):1113-24
3023663